Court overturns FDA rule on Laboratory-Developed Test Regulation in USA
Court overturns FDA rule on Laboratory-Developed Test Regulation in USA

The Association for Molecular Pathology (AMP) has achieved a major legal win after the U.S. District Court for the Eastern District of Texas ruled in its favor, vacating the FDAs controversial rule that sought to regulate laboratory-developed tests (LDTs) as medical devices. In a statement, AMP...